FDA Inspection
Fenwal International, Inc.Fenwal International, Inc. – FDA Inspection, Apr 25, 2023
Record Details
This FDA Inspection record concerns Fenwal International, Inc., with an inspection on April 25, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 7d702843-f19a-4cf0-9526-506bace84e14
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1203534
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
14- 21 CFR 820.70(f)Buildings
- 21 CFR 820.70(g)Equipment design and installation
- 21 CFR 820.100(a)Lack of or inadequate procedures
- 21 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
- 21 CFR 820.70(c)Environmental control Lack of or inadequate procedures
- 21 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
- 21 CFR 820.90(a)Nonconforming product control
- 21 CFR 820.100(a)Lack of or inadequate procedures
- 21 CFR 820.70(c)Environmental control Lack of or inadequate procedures
- 21 CFR 820.70(f)Buildings
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fenwal International, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 29, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Fenwal International, Inc.
- FDA Inspection 1116846 - 2019-11-15
- FDA Inspection 987674 - 2016-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.